Market Overview

Dr. Dre TV Show 'Vital Signs' Coming To Apple

Share:
Dr. Dre TV Show 'Vital Signs' Coming To Apple

Apple Inc. (NASDAQ: AAPL) is backing a "top-secret" scripted series starring Dr. Dre, according to a report by The Hollywood Reporter.

HR, citing "multiple sources," stated that Dr. Dre will also serve as an executive producer in Apple's original TV series, dubbed "Vital Signs." The report added that Apple is bankrolling the project, which will likely be distributed through Apple Music.

The series is said to be a "dark drama" with "no shortage of violence and sex." The show is also described as a semi-autobiographical chronicle of Dr. Dre with each episode "focusing on a different emotion and how Dre's character deals with it."

Sam Rockweel and MoMcCrae were named as additional cast members.

Dr. Dre already has a close relationship with Apple as he sold his Beats Electronics business to Apple for $3 billion in 2014.

Apple Originals

Apple's entry into the original content space has been speculated by Wall Street analysts and Apple fanatics for the past few years with some experts suggesting Apple should acquire Netflix, Inc. (NASDAQ: NFLX) for its original content and global streaming network.

Apple has experimented in the past with exclusive content in the past. The Hollywood Reporter pointed out that Apple streamed a Taylor Swift concert video and a visual version of DJ Kaheld's radio show. However, "Vital Signs" would mark Apple's "first concrete investment for the company in scripted television."

Posted-In: Apple Original TV Apple TV Dr Dre. The Hollywood Reporter Vital SignsNews Rumors Tech Best of Benzinga

 

Related Articles (AAPL + NFLX)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

JPMorgan Gains 7%, Approaching $57

Here's Why L Brands Lost More Than 3% On Friday